209 related articles for article (PubMed ID: 24549242)
1. A review of non-nucleoside anti-hepatitis B virus agents.
Zhang F; Wang G
Eur J Med Chem; 2014 Mar; 75():267-81. PubMed ID: 24549242
[TBL] [Abstract][Full Text] [Related]
2. Recent advance of the hepatitis B virus inhibitors: a medicinal chemistry overview.
Jia H; Rai D; Zhan P; Chen X; Jiang X; Liu X
Future Med Chem; 2015; 7(5):587-607. PubMed ID: 25921400
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule inhibitors for the treatment of hepatitis B virus documented in patents.
Geng CA; Wang LJ; Guo RH; Chen JJ
Mini Rev Med Chem; 2013 Apr; 13(5):749-76. PubMed ID: 23317498
[TBL] [Abstract][Full Text] [Related]
4. Naturally derived anti-hepatitis B virus agents and their mechanism of action.
Wu YH
World J Gastroenterol; 2016 Jan; 22(1):188-204. PubMed ID: 26755870
[TBL] [Abstract][Full Text] [Related]
5. Antiviral agents 3. Discovery of a novel small molecule non-nucleoside inhibitor of hepatitis B virus (HBV).
Crosby IT; Bourke DG; Jones ED; Jeynes TP; Cox S; Coates JA; Robertson AD
Bioorg Med Chem Lett; 2011 Mar; 21(6):1644-8. PubMed ID: 21333535
[TBL] [Abstract][Full Text] [Related]
6. Small Molecule Inhibitors of Hepatitis B Virus Nucleocapsid Assembly: A New Approach to Treat Chronic HBV Infection.
Yang L; Lu M
Curr Med Chem; 2018; 25(7):802-813. PubMed ID: 28675991
[TBL] [Abstract][Full Text] [Related]
7. Review of small synthetic molecules targeting HBV capsid assembly.
Liu N; Zhao F; Zhan P; Liu X
Med Chem; 2015; 11(8):710-6. PubMed ID: 25985859
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of helioxanthin analogues.
Janmanchi D; Lin CH; Hsieh JY; Tseng YP; Chen TA; Jhuang HJ; Yeh SF
Bioorg Med Chem; 2013 Apr; 21(7):2163-76. PubMed ID: 23465436
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
Liu Y; Peng Y; Lu J; Wang J; Ma H; Song C; Liu B; Qiao Y; Yu W; Wu J; Chang J
Eur J Med Chem; 2018 Jan; 143():137-149. PubMed ID: 29174810
[TBL] [Abstract][Full Text] [Related]
10. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
[TBL] [Abstract][Full Text] [Related]
12. Anti-HBV agents derived from botanical origin.
Qiu LP; Chen KP
Fitoterapia; 2013 Jan; 84():140-57. PubMed ID: 23164603
[TBL] [Abstract][Full Text] [Related]
13. Novel treatment options for hepatitis B virus infection.
Kumar R; Agrawal B
Curr Opin Investig Drugs; 2004 Feb; 5(2):171-8. PubMed ID: 15043391
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of novel strategies to combat hepatitis B virus targetting wild-type and drug-resistant mutants in experimental models.
Zoulim F
Antivir Chem Chemother; 2001; 12 Suppl 1():131-42. PubMed ID: 11594680
[TBL] [Abstract][Full Text] [Related]
15. Naturally occurring and synthetic bioactive molecules as novel non-nucleoside HBV inhibitors.
Zhan P; Jiang X; Liu X
Mini Rev Med Chem; 2010 Feb; 10(2):162-71. PubMed ID: 20408799
[TBL] [Abstract][Full Text] [Related]
16. [Anti-hepatitis B virus drugs].
Minami M
Nihon Rinsho; 2012 Apr; 70(4):609-13. PubMed ID: 22568141
[TBL] [Abstract][Full Text] [Related]
17. Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus.
Qu SJ; Wang GF; Duan WH; Yao SY; Zuo JP; Tan CH; Zhu DY
Bioorg Med Chem; 2011 May; 19(10):3120-7. PubMed ID: 21524588
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus.
Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W
Bioorg Med Chem; 2010 Jul; 18(14):5048-55. PubMed ID: 20639110
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in potential anti-hepatitis B virus agents: Structural and pharmacological perspectives.
Sun D; Zhu L; Yao D; Chen L; Fu L; Ouyang L
Eur J Med Chem; 2018 Mar; 147():205-217. PubMed ID: 29438889
[TBL] [Abstract][Full Text] [Related]
20. Advances in antiviral agents for hepatitis B virus.
Gumina G; Song GY; Chu CK
Antivir Chem Chemother; 2001; 12 Suppl 1():93-117. PubMed ID: 11594693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
